Dallas, TX 的 帕金森氏症 臨床試驗
9 項針對 帕金森氏症 的研究正在 Dallas（約 30 英里範圍內）及其周邊地點尋找參與者。開啟研究以查看參與資格及聯絡研究團隊的方式。
官方研究文本（英文）
正在為研究招募對象嗎？將此頁面置頂展示 — $99 / 30 天 →
A Phase 2 Study and Open-Label Extension of NEU-411 in Companion Diagnostic-Positive Participants With Early Parkinson's Disease
招募中2 期
- Neurology Consultants of Dallas PA, Dallas
Motor Network Physiology
招募中
- UT Southwestern Medical Center, Dallas
A Study to Evaluate the Efficacy, PK, Safety, and Tolerability of VIM0423 in Adults With Parkinson's Disease Tremor Insufficiently Responsive to Dopaminergic Therapy
招募中2 期
- Vima Site #063, Dallas
A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's Disease
招募中3 期
- Texas Neurology PA, Dallas
A Post-Approval Registry for Exablate 4000 Type 1.0 and Type 1.1 for Unilateral Pallidotomy for the Treatment of Advanced, Idiopathic Parkinson's Disease With Medication-refractory Moderate to Severe Motor Complications
招募中觀察性研究
- University of Texas Southwestern Medical Center, Dallas
Facilitating Diagnostics and Prognostics of Parkinsonian Syndromes Using Neuroimaging
招募中觀察性研究歡迎健康志工
- UT Southwestern Medical Center, Dallas
Action Regulation Behavioral
招募中歡迎健康志工
- University of Texas Southwestern Medical Center, Dallas
A Study of CREXONT (Carbidopa and Levodopa) Extended-Release Capsules in Participants With Parkinson's Disease
招募中4 期
- Neurology Consultants of Dallas, PA, Dallas
SegwayPD: The Effect of Sensory-augmented Postural Training Using Segway on Motor and Cognitive Function in Individuals With Parkinson's Disease
招募中
- University of Texas Southwestern Medical Center, Dallas
其他城市的 帕金森氏症 試驗
- New York City, NY23 項研究
- Boston, MA19 項研究
- Cleveland, OH18 項研究
- Minneapolis, MN17 項研究
- Nashville, TN15 項研究
- Philadelphia, PA14 項研究
- San Francisco, CA14 項研究
- New Haven, CT14 項研究
- Charleston, SC13 項研究
- Farmington Hills, MI13 項研究
- Chicago, IL13 項研究
- Miami, FL13 項研究
Dallas 的其他研究
- 乳癌55 項研究
- 非小細胞肺癌52 項研究
- 轉移性癌症42 項研究
- 心臟衰竭42 項研究
- 癌症（所有類型）37 項研究
- 前列腺癌36 項研究
- 大腸直腸癌33 項研究
- 肥胖症30 項研究
- 卵巢癌28 項研究
- 肺癌27 項研究
- 膀胱癌27 項研究
- 子宮內膜癌24 項研究
資料來源：ClinicalTrials.gov，擷取日期 2026年10月6日。各研究自行設定資格標準；由研究團隊決定參與者資格。